On 7/11/24, REGENXBIO Inc (NASDAQ: RGNX) stock enjoyed a major increase of 18.3%, closing at $12.71. Moreover, trading volume in this advance was exceptionally high at 254% of normal. Relative to the market the stock has been weak over the last nine months but has risen 18.2% during the last week.
Current PriceTarget Research Rating
RGNX is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
REGENXBIO has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. REGENXBIO has a poor Appreciation Score of 20 and a very low Power Rating of 9, producing the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment